Factor VIIa (Recombinant) and Lorcaserin Extended-Release Tablets
Determining the interaction of Factor VIIa (Recombinant) and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factor VIIa (Recombinant)-Lorcaserin Hydrochloride
- Factor VIIa (Recombinant)-Lorcaserin Tablets
- Factor VIIa (Recombinant)-Lorcet
- Factor VIIa (Recombinant)-Lorcet Plus
- Factor VIIa (Recombinant)-Lorcet Tablets
- Factor VIIa (Recombinant)-Lorlatinib
- Lorcaserin Extended-Release Tablets-Factor X (Human)
- Lorcaserin Extended-Release Tablets-Factor x human Intravenous
- Lorcaserin Extended-Release Tablets-Factor XIII
- Lorcaserin Extended-Release Tablets-Factor XIII (Human)
- Lorcaserin Extended-Release Tablets-Factor XIII A-Subunit (Recombinant)
- Lorcaserin Extended-Release Tablets-Factor XIII Concentrate (Human)